The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

A spontaneous coronary artery dissection, or SCAD, leads to bleeding inside the artery wall. A survivor shares her symptoms.

LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...

Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

Some clinicians prefer aspirin when balancing bleeding risk with the indication for an anticoagulant, Barnes said, reasoning ...

Robin Eaton wants women to trust their gut when it comes to their heart. In November 2023, the 46-year-old survived a spontaneous coronary artery dissection, or SCAD — a less common type of ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Doctors from Johns Hopkins University brought their groundbreaking practice ‘patient’ to Florida International University — a ...

James Pointer was in his housing unit at the Moberly Correctional Center when the cap on a femoral catheter became dislodged.

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...